Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05047536
Title KZR-261 in Subjects With Advanced Solid Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kezar Life Sciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
University Hospitals - Cleveland Medical Center Cleveland Ohio 44106 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville Nashville Tennessee 37203 United States Details
START (South Texas Accelerated Research Therapeutics) San Antonio Texas 78229 United States Details
Virginia Cancer Specialists (VCS) Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field